BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 20354771)

  • 1. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.
    Creighton CJ; Chang JC; Rosen JM
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):253-60. PubMed ID: 20354771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
    Micalizzi DS; Farabaugh SM; Ford HL
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
    Radisky ES; Radisky DC
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):201-12. PubMed ID: 20440544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNAs and EMT in mammary cells and breast cancer.
    Wright JA; Richer JK; Goodall GJ
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):213-23. PubMed ID: 20499142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
    Taylor MA; Parvani JG; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.
    Godde NJ; Galea RC; Elsum IA; Humbert PO
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):149-68. PubMed ID: 20461450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
    Blick T; Hugo H; Widodo E; Waltham M; Pinto C; Mani SA; Weinberg RA; Neve RM; Lenburg ME; Thompson EW
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):235-52. PubMed ID: 20521089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-to-mesenchymal transitions and circulating tumor cells.
    Bonnomet A; Brysse A; Tachsidis A; Waltham M; Thompson EW; Polette M; Gilles C
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):261-73. PubMed ID: 20449641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
    Sarrio D; Franklin CK; Mackay A; Reis-Filho JS; Isacke CM
    Stem Cells; 2012 Feb; 30(2):292-303. PubMed ID: 22102611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB/EGF signaling and EMT in mammary development and breast cancer.
    Hardy KM; Booth BW; Hendrix MJ; Salomon DS; Strizzi L
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):191-9. PubMed ID: 20369376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary gland studies as important contributors to the cause of epithelial mesenchymal plasticity in malignancy.
    Ford HL; Thompson EW
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):113-5. PubMed ID: 20544376
    [No Abstract]   [Full Text] [Related]  

  • 12. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression.
    de Herreros AG; Peiró S; Nassour M; Savagner P
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):135-47. PubMed ID: 20455012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.
    Herschkowitz JI; Zhao W; Zhang M; Usary J; Murrow G; Edwards D; Knezevic J; Greene SB; Darr D; Troester MA; Hilsenbeck SG; Medina D; Perou CM; Rosen JM
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2778-83. PubMed ID: 21633010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging roles of claudins in human cancer.
    Kwon MJ
    Int J Mol Sci; 2013 Sep; 14(9):18148-80. PubMed ID: 24009024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.
    Foroni C; Broggini M; Generali D; Damia G
    Cancer Treat Rev; 2012 Oct; 38(6):689-97. PubMed ID: 22118888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling.
    Guen VJ; Chavarria TE; Kröger C; Ye X; Weinberg RA; Lees JA
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10532-E10539. PubMed ID: 29158396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.
    May CD; Sphyris N; Evans KW; Werden SJ; Guo W; Mani SA
    Breast Cancer Res; 2011 Feb; 13(1):202. PubMed ID: 21392411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.
    Hollier BG; Evans K; Mani SA
    J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):29-43. PubMed ID: 19242781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathology of EMT in mouse mammary tumorigenesis.
    Cardiff RD
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):225-33. PubMed ID: 20521088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.
    Vetter G; Saumet A; Moes M; Vallar L; Le Béchec A; Laurini C; Sabbah M; Arar K; Theillet C; Lecellier CH; Friederich E
    Oncogene; 2010 Aug; 29(31):4436-48. PubMed ID: 20543867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.